Medicare Advantage

Decoding the New Interoperability & Prior Authorization Standards — Comment by June 15, 2026

Source published April 14, 2026

What Changed The proposed rule, outlined in the Federal Register (Policy ID: FR-2026-07205), aims to enhance the efficiency of billing processes within Medicare Advantage programs by improving the ele

Action required by

June 15, 2026

Review the Action Required section below and ensure your team has completed all compliance steps before this date.

What Changed The proposed rule, outlined in the Federal Register (Policy ID: FR-2026-07205), aims to enhance the efficiency of billing processes within Medicare Advantage programs by improving the electronic exchange of healthcare data and streamlining prior authorization procedures. Although the effective date has not been specified, the rule focuses on establishing interoperability standards that facilitate the sharing of patient information among providers, payers, and patients. This initiative is expected to reduce administrative burdens and delays associated with prior authorization requests, ultimately leading to quicker access to necessary medications and services for beneficiaries.

Why It Matters for Coding The proposed rule impacts claims submission by potentially altering how prior authorizations are processed, which could affect code selection and documentation requirements. While the rule does not specify changes to particular CPT, HCPCS, or ICD-10 codes, it emphasizes the need for improved data exchange that could impact a wide range of services covered under Medicare Advantage plans. Clinical coders should be prepared for updates regarding specific codes that may be included in future guidance, as well as potential revisions to coverage criteria and limitations.

Sign in to read the full article

Create a free account to access the complete analysis, action recommendations, and related alert references.

Content summarized from publicly available federal publications including CMS, MAC contractors, and the Federal Register. CLV Intelligence is not affiliated with or endorsed by any government agency. This is not legal or medical advice.